28/06/2018

CytoTools AG increases its stake in DermaTools Biotech GmbH (38.1 KiB)

23/02/2018

Court case in Frankfurt (45.4 KiB)

21/12/2017

DermaTools starts new European clinical trial (139.4 KiB)

14/12/2017

CytoTools AG strengthens its subsidiaries through capital increase (147.7 KiB)

30/11/2017

Invest Yorkville (143.3 KiB)

02/08/2017

CytoTools announces strengthening of senior management (109.2 KiB)

08/05/2018

CytoTools withdraws planned convertible bond (130.9 KiB)

31/01/2017

Extended strategy should accelerate development of CytoTools AG (148.5 KiB)

12/01/2017

Shareholders of DermaTools pave the way for the next round of financing (162.0 KiB)

21/10/2016

CytoTools announces personnel change (143.5 KiB)

26/08/2016

DermaTools action for damages (139.6 KiB)

24/05/2016

CytoTools_Ulcus cruris results from the phase II/III treatment (199.9 KiB)

27/04/2016

DermaTools signs contracts for production by a new German manufacturer (146.1 KiB)

03/02/2016

CytoTools AG strenghthens DermaTools Biotech GmbH with a capital increase (142.3 KiB)

14/12/2015

DermaPro retains its potential (131.7 KiB)

30/10/2015

CytoTools AG before important milestones (144.2 KiB)

22/10/2015

Successful share capital issue (137.0 KiB)

29/06/2015

CytoTools announces positive intermediate results for the European ulcus cruris trial (198.0 KiB)

17/06/2015

DermaTools Biotech GmbH capital increase (150.9 KiB)

22/05/2015

New advisory board member (126.8 KiB)

15/05/2015

Successful dialogue wih FDA (143.4 KiB)

15/04/2015

DermaPro: Complete Recruiting in Europe (131.6 KiB)

05/03/2015

Updates on European studies and approval status in India (135.8 KiB)

17/11/2014

CytoTools AG: DermaPro® now extended to US pharmaceuticals market (143.9 KiB)

25/07/2014

CytoTools AG: Clinical development (550.7 KiB)

23/07/2014

CytoTools AG: Annual General Meeting 2014 (144.6 KiB)

23/06/2014

CytoTools AG: Capital Increase CytoPharma GmbH (117.3 KiB)

05/05/2014

CytoTools AG: Clinical application dossier for a phase II_III trial submitted (163.1 KiB)

28/04/2014

CytoTools AG strengthens successful subsidiary DermaTools Biotech GmbH with further capital increase (148.4 KiB)

22/04/2014

CytoTools AG: Strategic move for a successful market launch of DermaPro® in India (152.4 KiB)

18/12/2013

CytoTools AG: Market authorization application submitted for DermaPro® in India (174.9 KiB)

05/12/2013

CytoTools AG announces the first order for the manufacture of DermaPro® for the Indian market (165.2 KiB)

17/10/2013

CytoTools AG announces a strategic reinforcement of the management board (45.8 KiB)

25/09/2013

CytoTools AG presented results of the Indian phase III trial with great success at one of Asia's largest diabetes conferences (48.1 KiB)

19/08/2013

CytoTools AG achieves breakthrough in treating diabetic foot with successful clinical Phase III study (95.1 KiB)

26/06/2013

DermaTools Biotech GmbH: Lizenzpartner Centaur Pharmaceuticals schließt klinische Phase III für diabetischen Fuß in Indien mit über 300 Patienten erfolgreich ab (28.8 KiB)

29/05/2013

Major participation by CytoTools AG and other existing shareholders in capital increase of successful subsidiary DermaTools Biotech GmbH and consequent securing of financing for all further clinical developments (96.1 KiB)

06/05/2013

CytoTools AG wins strong strategic institutional investor as new shareholder (98.1 KiB)

06/03/2013

Following a successful capital increase, CytoTools AG is set to expand the clinical development of DermaPro® (117.0 KiB)

16/01/2013

Final clinical phase III under way in Europe for DermaPro®, the lead wound healing product fromDermaTools Biotech GmbH (115.7 KiB)